Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases
- PMID: 11958825
- DOI: 10.1016/s0165-5728(01)00496-9
Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases
Abstract
We investigated the occurrence of T cells in the brain parenchyma of Alzheimer's disease (AD), non-AD degenerative dementias and controls by semi-quantitative analysis of immunohistochemically stained tissue sections. In all cases, we found at least some T cells. The number of T cells was increased in the majority of AD cases compared with other cases. The phenotype of T cells in the AD brain indicates that they are activated but are not fully differentiated. Antigen-triggered clonal expansion is not likely to take place. Local inflammatory conditions might cause accumulation and activation of T cells in the AD brain.
Similar articles
-
Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease.Neurobiol Aging. 2015 Jan;36(1):81-9. doi: 10.1016/j.neurobiolaging.2014.08.008. Epub 2014 Aug 23. Neurobiol Aging. 2015. PMID: 25277040
-
T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer's disease-like cerebral amyloidosis.Brain Behav Immun. 2016 May;54:211-225. doi: 10.1016/j.bbi.2016.02.009. Epub 2016 Feb 9. Brain Behav Immun. 2016. PMID: 26872418
-
Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease.Neurobiol Aging. 1988 Jul-Aug;9(4):339-49. doi: 10.1016/s0197-4580(88)80079-4. Neurobiol Aging. 1988. PMID: 3263583
-
T-cells in Alzheimer's disease.Neuromolecular Med. 2005;7(3):255-64. doi: 10.1385/NMM:7:3:255. Neuromolecular Med. 2005. PMID: 16247185 Review.
-
T Cells-Protective or Pathogenic in Alzheimer's Disease?J Neuroimmune Pharmacol. 2015 Dec;10(4):547-60. doi: 10.1007/s11481-015-9612-2. Epub 2015 May 10. J Neuroimmune Pharmacol. 2015. PMID: 25957956 Review.
Cited by
-
Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy.Front Aging Neurosci. 2021 May 17;13:658605. doi: 10.3389/fnagi.2021.658605. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34079449 Free PMC article.
-
Platelets in the Alzheimer's disease brain: do they play a role in cerebral amyloid angiopathy?Curr Neurovasc Res. 2015;12(1):4-14. doi: 10.2174/1567202612666150102124703. Curr Neurovasc Res. 2015. PMID: 25557380 Free PMC article.
-
Protection of TGF-β1 against neuroinflammation and neurodegeneration in Aβ1-42-induced Alzheimer's disease model rats.PLoS One. 2015 Feb 6;10(2):e0116549. doi: 10.1371/journal.pone.0116549. eCollection 2015. PLoS One. 2015. PMID: 25658940 Free PMC article.
-
Low-dose IL-2 Treatment Rescues Cognitive Deficits by Repairing the Imbalance Between Treg and Th17 Cells at the Middle Alzheimer's Disease Stage.J Neuroimmune Pharmacol. 2023 Dec;18(4):674-689. doi: 10.1007/s11481-023-10090-x. Epub 2023 Nov 14. J Neuroimmune Pharmacol. 2023. PMID: 37962810
-
Role of P2X7 Receptors in Immune Responses During Neurodegeneration.Front Cell Neurosci. 2021 May 26;15:662935. doi: 10.3389/fncel.2021.662935. eCollection 2021. Front Cell Neurosci. 2021. PMID: 34122013 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical